MeSH D010019 - osteomyelitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ciprofloxacin | Ciprofloxacin |  | 2004-06-09 |  |  |
| Cloxacillin | Cloxacillin |  | 1982-01-01 |  |  | |
| Dicloxacillin | Dicloxacillin |  | 1982-06-03 |  |  | |
| Oxacillin | Oxacillin |  | 1982-01-01 |  |  | |
| Taro Pharmaceutical | Ciprofloxacin | Ciprofloxacin |  | 2004-10-06 |  |  |
| NATCO Pharma | Ciprofloxacin | Ciprofloxacin |  | 2004-06-09 |  |  |
| GSK | Oxacillin | Bactocill |  | 1982-01-01 |  |  |
| Cloxacillin | Cloxapen |  | 1982-01-01 |  |  | |
| Dicloxacillin | Dycill |  | 1982-01-01 |  |  | |
| Nafcillin | Nallpen |  | 1982-01-01 |  |  | |
| Chartwell Pharmaceuticals | Dicloxacillin | Dicloxacillin |  | 1982-01-01 |  |  |
| Ciprofloxacin | Ciprofloxacin |  | 2004-11-04 |  |  | |
| Sandoz | Nafcillin | Nafcillin |  | 1984-08-02 |  |  |
| Oxacillin | Oxacillin |  | 1982-01-01 |  |  | |
| Ciprofloxacin | Ciloxan |  | 1990-12-31 |  |  | |
| Hydrocortisone, Ciprofloxacin | Cipro |  | 1998-02-10 |  |  | |
| Dexamethasone, Ciprofloxacin | Ciprodex | 2025-06-04 | 2003-07-18 |  |  | |
| Wyeth | Dicloxacillin | Pathocil |  | 1982-01-01 |  |  |
| Nafcillin | Unipen |  | 1986-12-16 |  |  | |
| Bayer | Ciprofloxacin | Cipro |  | 1987-10-22 |  |  |
| Aurobindo Pharma | Ciprofloxacin | Ciprofloxacin |  | 2007-04-26 |  |  |
| Dicloxacillin | Dicloxacillin |  | 2022-09-23 |  |  | |
| Barr Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2004-06-09 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
67%6/9
Phase 3
85%11/13
Approved: 6Overall Success rate: 38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use